{"id":39413,"date":"2021-09-01T17:31:27","date_gmt":"2021-09-02T00:31:27","guid":{"rendered":"https:\/\/lapost.us\/?p=39413"},"modified":"2021-09-01T17:31:27","modified_gmt":"2021-09-02T00:31:27","slug":"pfizer-launches-covid-19-pill-trial","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=39413","title":{"rendered":"PFIZER LAUNCHES\u00a0COVID-19 PILL TRIAL"},"content":{"rendered":"<p>Pfizer on Wednesday announced that it had initiated a later-stage clinical trial for a pill that could potentially treat COVID-19.<\/p>\n<p><strong>An unmet need:\u00a0<\/strong>If proven to be safe and effective, the drug could fill a need for a widespread, easier-to-use treatment, as opposed to an infusion like remdesivir, another treatment.<\/p>\n<p>Pfizer is beginning a trial that will enroll 1,140 participants, the company said.<\/p>\n<p>The drug could eventually be used in a &#8220;broad&#8221; population of patients, Pfizer said, namely people who have symptomatic cases of COVID-19 and are not hospitalized or at risk of severe illness.<\/p>\n<p>A separate trial began in July for people who are at risk of severe illness.<\/p>\n<p>\u201cSuccess against #COVID19 will likely require both vaccines &amp; treatments,\u201d Pfizer CEO Albert Bourla tweeted on Wednesday. \u201cWe\u2019re pleased to share we\u2019ve started a Phase 2\/3 study of our oral antiviral candidate\u2014specifically designed to combat SARS-CoV-2\u2014in non-hospitalized, low-risk adults.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer on Wednesday announced that it&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,16,12],"tags":[],"class_list":["post-39413","post","type-post","status-publish","format-standard","hentry","category-business","category-health","category-science-tech"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/39413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39413"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/39413\/revisions"}],"predecessor-version":[{"id":39414,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/39413\/revisions\/39414"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}